← Leaderboards
Michael R Bishop
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Clinical Sciences
Same institution · by research overlap
- Steven A Rosenberg$0
- Louis Staudt$0
- Larry W Kwak$10,852,773
- James C Yang$0
- Wyndham H Wilson$0
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsNeoplasm /Cancer ImmunotherapyStem Cell TransplantationHomologous TransplantationHistocompatibility TypingAutologous TransplantationBreast NeoplasmsGraft Versus Host DiseaseHuman Therapy EvaluationNeoplasm /Cancer VaccineHuman SubjectB Cell LymphomaCytotoxic T LymphocyteMetastasisHelper T LymphocyteClinical ResearchCooperative StudyDevelopmental ImmunologyAntigensDoctor Of MedicineAllograftingDesignDonor Lymphocyte InfusionBase
Grant awards (9)
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT$463,757
Z01 · FY2008 · CA · contact PI
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT$689,605
Z01 · FY2007 · CA · contact PI
Optimizing the Graft-Versus-Tumor Effect in Allogeneic H$0
Z01 · FY2006 · SC · contact PI
Optimization of the Graft-Versus-Tumor Effect in Allogen$0
Z01 · FY2005 · SC
Investigation of Graft Versus Tumor Effects in Non-hemat$0
Z01 · FY2004 · SC
Investigation of Graft Versus Tumor Effects in Non-hemat$0
Z01 · FY2003 · SC
Investigation of Graft Versus Tumor Effects in Non-hemat$0
Z01 · FY2002 · SC
Graft Versus Tumor Effects in Non-hematologic Maligancy$0
Z01 · FY2001 · SC
GRAFT VERSUS TUMOR EFFECTS IN NONHEMATOLOGIC MALIGNANCY$0
Z01 · FY2000 · SC